ATLX-2199

N/A

Report date: 2025/06/24 15:02:12

Base Information

Drug NameATLX-2199
Drug Alias NameATLX-2199
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMuscular AtrophyParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlchemab Therapeutics Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMuscular AtrophyParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A